1Bradley A.J. and M.J. Green. An Investigation of Factors Affecting Cure when Treating Clinical Mastitis in Dairy Cattle with Cephalosporin Containing Intramammary Preparationsin[A]. Proceedings of International Conference Mastitis ControlJC]. The Hague, 2008.
2Martin A.R. Antibacterial Antibiotics [M]. New York, 1998, 253-326.
3Hornish R.E. and S.F. Kotarski. Cephalosporins in Veterinary Medicine-Ceftiofnruse in food animals[J]. Current Topics in Medicinal Chemistry, 202, 2:717-731.
4Gehring R. and G.W. Smith An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis[J]. Journal of Veterinary Phamaacology and Therapeutics, 2006,29:237-241.
5Friton G. Minimal inhibitory concentration of selected antibiotics in current bacterial isolates from bovine mastitis milk. Bl Vetmedica Study Project, 20(5.
6Pillai S., P,,. C. Moellering and G. M. Eliopoulos .Antimicrobial combinations Ill V. Lorian[M]. Antibiotics in laboratory medicine, 2005,365-424.
7Davis B.D.Bactericidal synergism between beta-lactams and aminoglycosides: mechanism and possible therapeutic implications[J], l<ev Infect Dis.,1982,4(2):237-45.
8Mouton J.W., M.N. Dudley, O. Cars, et al. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-inffctive drug[J]. International Journal of Antimicrobial Agents,2002,19: 355-358..
